Showing results (1-10 of 280) with videos related to
Sort By:
Pageof 28
Schizophrenia Bulletin|January 1, 1980
Demographic, biologic, and other variables affecting monoamine oxidase activityD S Robinson, A NiesModern Problems of Pharmacopsychiatry|January 1, 1975
Genetics of monoamine oxidaseD S Robinson, A NiesThe American Journal of Psychiatry|April 1, 1985
Response to phenelzine among depressed patients with features of hysteroid dysphoriaA Kayser, D S Robinson, A Nies, et al.American Family Physician|July 1, 1978
Use of MAOI antidepressantsC L Ravaris, D S Robinson, A Nies, et al.Archives of General Psychiatry|September 1, 1980
Phenelzine and amitriptyline in the treatment of depression. A comparison of present and past studiesC L Ravaris, D S Robinson, J O Ives, et al.Archives of General Psychiatry|May 1, 1978
Clinical pharmacology of phenelzineD S Robinson, A Nies, C L Ravaris, et al.The Journal of Clinical Psychiatry|May 1, 1982
Cardiovascular effects of phenelzine and amitriptyline in depressed outpatientsD S Robinson, A Nies, J Corcella, et al.Archives of General Psychiatry|March 1, 1976
A multiple-dose, controlled study of phenelzine in depression-anxiety statesC L Ravaris, A Nies, D S Robinson, et al.Journal of Clinical Psychopharmacology|October 1, 1983
Plasma levels of catecholamines and dihydroxyphenylglycol during antidepressant drug treatmentD S Robinson, G A Johnson, A Nies, et al.Psychopharmacology|June 21, 1979
Plasma tricyclic drug levels in amitriptyline-treated depressed patientsD S Robinson, T B Cooper, C L Ravaris, et al.Pageof 28